NTNX Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency Lyell Immunopharma LYEL Q1 2026 Earnings Narrower Loss Beats Estimates as Biotech Advances Pipeline HRTG Q1 2026 Earnings EPS Misses Estimates as Underwriting Pressures Persist Gen Digital Inc Q1 2026 Earnings EPS Beats Estimates Amidst Mixed Market Reception CanFite Biopharma Q4 2023 Earnings Significant EPS Surprise as Biotech Focuses on Clinical Pipeline Kaltura Q1 2026 Earnings EPS Surges Past Estimates as Profitability Improves